Status:
UNKNOWN
Percentage Visualized Mucosa as a Marker for the Quality of Colonoscopy
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Colonoscopy
Eligibility:
All Genders
18+ years
Brief Summary
Primary hypothesis: The percentage of mucosa visualized during the withdrawal of a colonoscopy with reference to the position in the colon by means of the scope-guide is an appropriate parameter for a...
Detailed Description
PROJECT OBJECTIVES AND DESIGN 1.1 Hypothesis Primary hypothesis: The percentage of mucosa visualized during the withdrawal of a colonoscopy with reference to the position in the colon by means of the ...
Eligibility Criteria
Inclusion
- Signed informed consent.
- Ability to understand and follow study procedures and understand informed consent.
- Complete colonoscopy.
- Age at least 18 years.
Exclusion
- \- Participation in another clinical study interfering with study procedures.
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04482452
Start Date
June 8 2020
End Date
May 19 2022
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital
Bern, Switzerland, 3010